Jane S. Ricciuti, RPh, MS


January 29, 2004

In This Article

Cardiovascular Agents

(atenolol) Tablets

Manufacturer: AstraZeneca Pharmaceuticals LP

Drug Approval Classification: Supplemental New Drug Application (Approval Date: 11/06/03)

Warnings/Precautions: The labeling for Tenormin (atenolol) has been revised for the addition of the following paragraph to the "Warnings/Pregnancy and Fetal Injury" and the "Precautions/Nursing Mothers" sections:

  • Neonates born to mothers who are receiving atenolol at parturition or breast-feeding may be at risk for hypoglycemia. Caution should be exercised when atenolol is administered during pregnancy or to a woman who is breast-feeding.

Tenormin (atenolol) Tablets Letter

Medscape DrugInfo

Tenormin (atenolol) Tablets